Dr. Ardaman Shergill, MD
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Area of expertise
Colorectal Cancer
Ardaman Shergill, MD has run 10 trials for Colorectal Cancer. Some of their research focus areas include:
Pancreatic Cancer
Ardaman Shergill, MD has run 7 trials for Pancreatic Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Chicago Comprehensive Cancer Center
UC Comprehensive Cancer Center At Silver Cross
Clinical Trials Ardaman Shergill, MD is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting
2 awards
Phase 3
2 criteria
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting
1 award
Phase 2 & 3
10 criteria
More about Ardaman Shergill, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Ardaman Shergill, MD has experience with
- Cisplatin
- Irinotecan
- Fluorouracil
- Cetuximab
- Atezolizumab
- Oxaliplatin
Breakdown of trials Ardaman Shergill, MD has run
Colorectal Cancer
Pancreatic Cancer
Colon Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ardaman Shergill, MD specialize in?
Ardaman Shergill, MD focuses on Colorectal Cancer and Pancreatic Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ardaman Shergill, MD currently recruiting for clinical trials?
Yes, Ardaman Shergill, MD is currently recruiting for 9 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Ardaman Shergill, MD has studied deeply?
Yes, Ardaman Shergill, MD has studied treatments such as Cisplatin, Irinotecan, Fluorouracil.
What is the best way to schedule an appointment with Ardaman Shergill, MD?
Apply for one of the trials that Ardaman Shergill, MD is conducting.
What is the office address of Ardaman Shergill, MD?
The office of Ardaman Shergill, MD is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.